1. A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance. (12th March 2020) Authors: Vossen, A.R.J.V.; van Straalen, K.R.; Swagemakers, S.M.A.; de Klein, J.E.M.M.; Stubbs, A.P.; Venter, D.J.; van der Zee, H.H.; van der Spek, P.J.; Prens, E.P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 10(2020) Page Start: 2353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers. (10th December 2018) Authors: Vossen, A.R.J.V.; van der Zee, H.H.; Davelaar, N.; Mus, A.M.C.; van Doorn, M.B.A.; Prens, E.P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 4(2019) Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient‐reported quality of life and objective disease severity assessment. (1st May 2019) Authors: Rondags, A.; van Straalen, K.R.; van Hasselt, J.R.; Janse, I.C.; Ardon, C.B.; Vossen, A.R.J.V.; Prens, E.P.; van der Zee, H.H.; Horváth, B. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient‐reported quality of life and objective disease severity assessment. (25th February 2019) Authors: Rondags, A.; van Straalen, K.R.; van Hasselt, J.R.; Janse, I.C.; Ardon, C.B.; Vossen, A.R.J.V.; Prens, E.P.; van der Zee, H.H.; Horváth, B. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group. (23rd October 2018) Authors: Zouboulis, C.C.; Bechara, F.G.; Dickinson‐Blok, J.L.; Gulliver, W.; Horváth, B.; Hughes, R.; Kimball, A.B.; Kirby, B.; Martorell, A.; Podda, M.; Prens, E.P.; Ring, H.C.; Tzellos, T.; van der Zee, H.H.; van Straalen, K.R.; Vossen, A.R.J.V.; Jemec, G.B.E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 1(2019) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sequence variants in hidradenitis suppurativa: in search of the pathogenic mechanisms. (1st October 2017) Authors: Vossen, A.R.J.V.; van der Zee, H.H.; Prens, E.P. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sequence variants in hidradenitis suppurativa: in search of the pathogenic mechanisms. (20th October 2017) Authors: Vossen, A.R.J.V.; van der Zee, H.H.; Prens, E.P. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (IL)‐17A, IL‐12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. (12th April 2019) Authors: Vossen, A.R.J.V.; Ardon, C.B.; van der Zee, H.H.; Lubberts, E.; Prens, E.P. Journal: British journal of dermatology Issue: Volume 181:Number 2(2019) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (IL)‐17A, IL‐12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. (1st August 2019) Authors: Vossen, A.R.J.V.; Ardon, C.B.; van der Zee, H.H.; Lubberts, E.; Prens, E.P. Journal: British journal of dermatology Issue: Volume 181:Number 2(2019) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗